"Designing Growth Strategies is in our DNA"
The U.S. insulin pump market size was valued at USD 2.58 billion in 2022. The market is projected to grow from USD 2.98 billion in 2023 to USD 8.53 billion by 2030, exhibiting a CAGR of 16.2% during the forecast period.
An insulin pump is a portable medical device that helps manage blood sugar levels in a diabetic patient. It delivers continuous and customized doses of rapid-acting insulin either by a steady flow (basal) or extra portion during mealtime (bolus). The demand for insulin delivery devices is increasing due to the rise in type 1 diabetes prevalence among the U.S. population. Moreover, the rising introduction and availability of diabetes management technologies, such as pump therapy and Continuous Glucose Monitors (CGM), have made patients more independent in managing the disease. Thus, the adoption of these pumps is expected to gain momentum owing to the rising awareness and easy availability of these portable insulin devices in the U.S.
Also, higher advantages of these pumps over conventional pens and Metered Dose Inhaler (MDI) therapies, such as high adherence and less invasive, have further enhanced adoption among the patients, further propelling the market growth
Decline in Diabetes Diagnosis and Decreased Product Sales amid COVID-19 Pandemic Hampered Market
The COVID-19 pandemic significantly impacted the market growth during the forecast period. The pandemic led to the imposition of countrywide lockdowns and the slowdown of medical devices and consumables supply across the U.S. Also, the number of diabetic patients visiting hospitals and healthcare centers for insulin therapy decreased due to healthcare professionals’ high focus on treating the COVID-19-affected population. Moreover, major market players reported a decline in insulin pump revenues due to decreased demand and sales in 2020.
However, the withdrawal of lockdown measures led to a surge in the diagnosis of diabetes and its treatment among patients. Thus, due to the rise in diagnosis rates, patients' demand for portable insulin delivery devices and consumables increased post-pandemic. Moreover, rising approval of regulatory agencies for technologically advanced pumps and strategic collaborations for new device production further augmented the market growth.
Thus, the surge in collaborations for new product launches by key players post the COVID-19 pandemic and high adoption of pumps among the population propelled the U.S. insulin pump market growth.
Request a Free sample to learn more about this report.
Surge in Launch of New Generation Pumps by Market Players to Boost Market Growth
The awareness of insulin delivery devices is high among the U.S. population, owing to the high prevalence of type 1 diabetes. This scenario has led to the high demand for and adoption of new-generation pumps among the underserved diabetic population. Moreover, growing patient preference and recommendations of health professionals for diabetes self-management might further aid in market growth.
Thus, several players are focusing on the launch and commercialization of advanced pumps in the market for diabetes monitoring and management among patients. The recent and ongoing developments in Continuous Glucose Monitoring (CGM) technology and Automated Insulin Delivery (AID) algorithms in conjunction with insulin pump therapy provide several benefits for patients suffering from insulin-dependent diabetes.
Thus, rising awareness of insulin delivery systems among diabetic patients and the rise in approval of technologically advanced pumps and consumables in the U.S. will foster the market growth.
Favorable Reimbursement Policies to Propel Product Demand
The demand for these pumps is high owing to the rising prevalence of type 1 diabetes and the need for insulin among adults and children. However, the cost of devices and consumables is rising due to new technological advancements or pharmaceutical supply constraints, thereby limiting their adoption. Thus, policymakers, health insurance companies, and regulatory agencies are initiating new policies to increase the uptake and use of new diabetes management technologies. Also, the development of new strategies to cover the cost of insulin and its delivery devices by government authorities in the U.S. will boost the adoption of these devices among diabetic patients.
Moreover, new reforms in existing coverage plans by health insurers for technologically advanced pumps will further boost the population's demand for these devices.
Thus, such initiatives of cost coverage through new reimbursement policies will boost the product demand among patients, further driving the market growth.
Adverse Events Associated with Pumps May Limit Market Growth
Insulin pumps are used to monitor and manage high blood sugar levels among patients with type 1 diabetes. However, prolonged use of these pumps may lead to adverse events, such as hypoglycemia, skin infections, and electrolyte disturbances among diabetic patients. Moreover, the surge in patient adoption of these devices may lead to a rise in reports of adverse events among the population, further limiting the market growth.
Also, device failures may cause adverse reactions related to either hyperglycemia or hypoglycemia among patients. The failure of these devices can be attributed to mechanical failures, blockages within the infusion sets, infusion site complications, instability of the insulin stored within the pump, and user error.
Thus, rising adverse events associated with pumps and the system, and its negative effects on patient therapy may restrict the adoption of pumps, further hampering the market growth.
Rising Adoption of Pumps Due to Their Distinct Benefits Will Augment Segment Growth
Based on product type, the market is segmented into pumps and consumables.
Pumps segment accounted for the largest market share in 2022 and mainly contains insulin reservoirs and batteries. The rising demand for these products was attributable to the growing need for and adoption of rapid-acting insulin for basal conditions among the diabetic population. Moreover, distinct advantages and increased awareness of pump therapy compared to other available insulin therapies will continue to generate demand for these devices and pump-related supplies among the U.S. population, further propelling the segment’s growth rate.
The consumables segment is expected to register a substantial CAGR during the forecast period. This segment’s growth is attributed to the rising production and introduction of new analog products by key players in the U.S. Moreover, rising partnerships among market players for developing novel products with recent technologies will further foster the segment’s growth.
To know how our report can help streamline your business, Speak to Analyst
Rising Prevalence of Type 1 Diabetes to Boost Demand for Insulin Pumps
On the basis of disease indication, the market is segmented into type 1 diabetes and type 2 diabetes.
The type 1 diabetes segment is anticipated to exhibit a robust CAGR during the forecast timeframe. This is due to the rising demand for insulin and insulin delivery devices to treat type 1 diabetes among patients. Moreover, the rising prevalence of this disease in adults and children will further augment the segmental growth rate.
The type 2 diabetes segment is estimated to grow slower than the type 1 segment due to a substantial rise in its prevalence among the U.S. population yet moderate demand for these pumps among type 2 diabetic patients.
Growing Initiatives to Enhance Retail & Online Pharmacy Network to Augment Segment Growth
On the basis of distribution channel, the market is segmented into hospital pharmacy, and retail & online pharmacy.
The retail & online pharmacy segment is expected to record a higher CAGR during the forecast period owing to rising direct sales of insulin delivery products at these pharmacies. Also, the growing initiatives of key players to enhance their distribution network by expanding their retail pharmacy channels will further boost the segmental growth.
The hospital pharmacy segment is estimated to register a substantial CAGR during the forecast period. The growth is owing to the increasing rate of diabetes diagnosis in hospitals across the U.S. and rising number of patients visiting hospitals for insulin treatment.
Major Companies Use Collaboration Strategy to Boost their Market Position
The market is characterized by dominant players, such as Medtronic, Insulet Corporation and Tandem Diabetes Care, Inc. Medtronic held a dominant market share in 2022, owing to the presence of a strong product portfolio and global distribution channel for diabetes care.
The other significant players, such as Ypsomed AG and Insulet Corporation are now focusing on introducing advanced pumps and emphasizing strategic partnerships and collaborations to strengthen their position in this market. These factors will enhance the company’s position in the market, further propelling the U.S. insulin pump market share in the global market.
To gain extensive insights into the market, Request for Customization
The market research report provides a detailed market analysis. It focuses on key aspects, such as the launch of new products, technological advancements, and the prevalence of diabetes. Besides this, the report offers insights into the latest market trends and highlights key industry developments, such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. In addition to the above-mentioned factors, the report encompasses several factors that have contributed to the market's growth in recent years.
CAGR of 16.2% from 2023-2030
Value (USD billion)
By Product Type, Disease Indication, Distribution Channel
By Product Type
By Disease Indication
By Distribution Channel
Fortune Business Insights says that the global market size was USD 2.58 billion in 2022 and is projected to reach USD 8.53 billion by 2030.
In 2022, the market value stood at USD 2.58 billion.
Registering a CAGR of 16.2%, the market will exhibit steady growth in the forecast period of 2023-2030.
The pumps segment is expected to lead this market during the forecast period.
Increasing prevalence of type 1 diabetes and rising insulin pump launches are some of the key factors driving the market.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry